XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders’ Equity (Deficit) (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Equity [Abstract] |
Summary of Series F Activity | A summary of the Series F activity for the three months ended March 31, 2025 is as follows: Summary of Series F Activity
Date of Purchase |  | Shares Purchased |  |  | Gross Proceeds |  |  | Net Proceeds |  |  | Original Conversion Price |  |  | Shares Outstanding December 31, 2024 |  |  | Series F Converted |  |  | Shares Outstanding March 31, 2025 |  |  | Conversion Price at March 31, 2025 |  |  | Shares Issuable at March 31, 2025 |
November 15, 2023 |  |  | 1,850 |  |  | $ | 1,850,000 |  |  | $ | 1,850,000 |  |  | $ | 124.70 |  |  |  | 150 |  |  |  | — |  |  |  | 150 |  |  | $ | 1.10 |  |  |  | 136,364 |
March 6, 2024 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 950,000 |  |  |  | 60.29 |  |  |  | 435 |  |  |  | (335 | ) |  |  | 100 |  |  |  | 1.10 |  |  |  | 90,909 |
April 12, 2024 |  |  | 1,050 |  |  |  | 1,050,000 |  |  |  | 1,050,000 |  |  |  | 37.00 |  |  |  | 1,050 |  |  |  | (1,050 | ) |  |  | — |  |  |  | 1.10 |  |  |  | — |
May 31, 2024 |  |  | 1,050 |  |  |  | 1,050,000 |  |  |  | 1,025,000 |  |  |  | 32.15 |  |  |  | 1,050 |  |  |  | (525 | ) |  |  | 525 |  |  |  | 1.10 |  |  |  | 477,273 |
July 25, 2024 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 23.15 |  |  |  | 500 |  |  |  | (500 | ) |  |  | — |  |  |  | 1.10 |  |  |  | — |
August 27, 2024 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 20.19 |  |  |  | 500 |  |  |  | — |  |  |  | 500 |  |  |  | 1.10 |  |  |  | 454,545 |
October 1, 2024 (i) |  |  | 1,500 |  |  |  | — |  |  |  | — |  |  |  | 12.00 |  |  |  | 1,500 |  |  |  | — |  |  |  | 1,500 |  |  |  | 1.10 |  |  |  | 1,363,636 |
December 18, 2024 |  |  | 750 |  |  |  | 750,000 |  |  |  | 750,000 |  |  |  | 5.25 |  |  |  | 750 |  |  |  | — |  |  |  | 750 |  |  |  | 1.20 | (ii) |  |  | 623,131 |
February 7, 2025 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 1,000,000 |  |  |  | 2.22 |  |  |  | — |  |  |  | — |  |  |  | 1,000 |  |  |  | 1.20 | (ii) |  |  | 830,841 |
March 17, 2025 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 1.20 |  |  |  | — |  |  |  | — |  |  |  | 500 |  |  |  | 1.20 |  |  |  | 415,420 |
Total March 31, 2025 |  |  | 9,700 |  |  | $ | 8,200,000 |  |  | $ | 8,125,000 |  |  | $ | — |  |  |  | 5,935 |  |  |  | (2,410 | ) |  |  | 5,025 |  |  | $ | — |  |  |  | 4,392,119 |
| (i) | These shares were issued as consideration for executing the Omnibus Agreement in connection with the October 2024 Offering
| (ii) | Reflects the conversion price after the March 2025 Down Round Trigger that was triggered with the Sale of Series F on March 17, 2025.
AGEAGLE AERIAL SYSTEMS INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024 (UNAUDITED) Note 7 – Stockholders’ Equity (Deficit) – Continued A summary of the Series F activity for the three months ended March 31, 2024, is as follows:
Date of Purchase |  |  | Shares Purchased |  |  | Gross Proceeds |  |  | Net Proceeds |  |  | Original Conversion Price |  |  | Shares Outstanding December 31, 2023 |  |  | Series F Converted |  |  | Shares Outstanding March 31, 2024 |  |  | Conversion Price at March 31, 2024 |  |  | Shares Issuable at March 31, 2024 |
June 26, 2022 |  |  |  | 10,000 |  |  | $ | 10,000,000 |  |  | $ | 9,920,000 |  |  | $ | 620.00 |  |  |  | 2,925 |  |  |  | (2,925 | ) |  |  | — |  |  | $ | 30.00 |  |  |  | — |
March 10, 2023 |  |  |  | 3,000 |  |  |  | 3,000,000 |  |  |  | 3,000,000 |  |  |  | 420.00 |  |  |  | 3,000 |  |  |  | (205 | ) |  |  | 2,795 |  |  |  | 30.00 |  |  |  | 93,167 |
November 15, 2023 |  |  |  | 1,850 |  |  |  | 1,850,000 |  |  |  | 1,850,000 |  |  |  | 124.70 |  |  |  | 150 |  |  |  | — |  |  |  | 150 |  |  |  | 30.00 |  |  |  | 5,000 |
March 6, 2024 |  |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 950,000 |  |  |  | 60.29 |  |  |  | — |  |  |  | — |  |  |  | 1,000 |  |  |  | 30.00 |  |  |  | 33,333 |
Total March 31, 2024 |  |  |  | 15,850 |  |  | $ | 15,850,000 |  |  | $ | 15,720,000 |  |  | $ | — |  |  |  | 6,075 |  |  |  | (3,130 | ) |  |  | 3,945 |  |  | $ | — |  |  |  | 131,500 |
Schedule of Deemed Dividends From various Down Round Triggers | Below is a summary of the deemed dividends resulting from the March 2025 and 2024 Down Round Triggers: Schedule of Deemed Dividends From various Down Round Triggers
Deemed Dividends on Series F Preferred Stock
Date of Trigger Event |  | Description of Trigger Event |  | Series F Triggered |  | Conversion Prices Prior to Trigger |  | Conversion Price After Trigger |  | Incremental Value Deemed Dividend
March 17, 2025 |  | March 2025 Down Round Trigger |  |  | 5,025 |  |  | $ | 2.22 - 5.25 |  |  | $ | 1.20 |  |  | $ | 976,637 |
Deemed Dividends on Series F Warrants |
March 17, 2025 |  | March 2025 Down Round Trigger |  |  | 593,247 |  |  | $ | 2.22 - 5.25 |  |  | $ | 1.20 |  |  | $ | 79,695 |
Total Deemed Dividends |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 1,056,332 |
Series F and Series F Warrants issued prior to December 2024 have conversion and exercise prices equal to $1.10 and were not impacted by the March 2025 Down Round Trigger.
Deemed Dividends on Series F Preferred Stock
Date of Trigger Event |  | Description of Trigger Event |  | Series F Triggered |  | Conversion Prices Prior to Trigger |  | Conversion Price After Trigger |  | Incremental Value Deemed Dividend
March 6, 2024 |  | March 2024 Down Round Trigger |  |  | 3,945 |  |  | $ | 60.29 - 124.50 |  |  | $ | 30.00 |  |  | $ | 5,102,674 |
Deemed Dividends on Series F Warrants |
March 6, 2024 |  | March 2024 Down Round Trigger |  |  | 54,695 |  |  | $ | 60.29 - 124.50 |  |  | $ | 30.00 |  |  | $ | 147,030 |
Total Deemed Dividends |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 5,249,704 |
Summary of Restricted Stock Units Activity | For the three months ended March 31, 2025, a summary of RSU activity is as follows: Summary of Restricted Stock Units Activity
|  | Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2024 |  |  | 7,293 |  |  | $ | 324.64 |
Granted |  |  | 72,194 |  |  |  | 2.10 |
Cancelled |  |  | (1,072 | ) |  |  | 264.60 |
Vested and released |  |  | — |  |  |  | — |
Outstanding as of March 31, 2025 |  |  | 78,415 |  |  |  | 28.57 |
Vested as of March 31, 2025 |  |  | 8,015 |  |  |  | 255.33 |
Unvested as of March 31, 2025 |  |  | 70,400 |  |  | $ | 2.75 |
For the three months ended March 31, 2024, a summary of RSU activity is as follows:
|  | Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2023 |  |  | 3,054 |  |  | $ | 901.50 |
Granted |  |  | — |  |  |  | — |
Cancelled |  |  | (9 | ) |  |  | 467.00 |
Vested and released |  |  | — |  |  |  | — |
Outstanding as of March 31, 2024 |  |  | 3,045 |  |  |  | 903.00 |
Vested as of March 31, 2024 |  |  | 2,869 |  |  |  | 928.00 |
Unvested as of March 31, 2024 |  |  | 176 |  |  | $ | 494.50 |
Summary of Options Activity | For the three months ended March 31, 2025 a summary of the options activity is as follows: Summary of Options Activity
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Fair Value |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2024 |  |  | 56 |  |  | $ | 5,342 |  |  | $ | 2,874 |  |  |  | 1.23 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired/Forfeited |  |  | (5 | ) |  |  | 410 |  |  |  | 247 |  |  |  | — |  |  |  | — |
Outstanding as of March 31, 2025 |  |  | 51 |  |  | $ | 5,825 |  |  | $ | 3,131 |  |  |  | 0.95 |  |  | $ | — |
Exercisable as of March 31, 2025 |  |  | 51 |  |  | $ | 5,825 |  |  | $ | 3,131 |  |  |  | 0.95 |  |  | $ | — |
For the three months ended March 31, 2024, a summary of the options activity is as follows:
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Fair Value |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2023 |  |  | 2,505 |  |  | $ | 2,000 |  |  | $ | 1,080 |  |  |  | 1.49 |  |  | $ | 2,294 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired/Forfeited |  |  | (1,203 | ) |  |  | 2,055 |  |  |  | 1,126 |  |  |  | — |  |  |  | — |
Outstanding as of March 31, 2024 |  |  | 1,302 |  |  | $ | 2,010 |  |  | $ | 1,082 |  |  |  | 2.36 |  |  | $ | — |
Exercisable as of March 31, 2024 |  |  | 1,177 |  |  | $ | 2,184 |  |  | $ | 1,178 |  |  |  | 2.19 |  |  | $ | — |

X
- Definition Schedule Of Deemed Dividends From Various Down Round Triggers [Table Text Block] + References No definition available. + Details
Name: | UAVS_ScheduleOfDeemedDividendsFromVariousDownRoundTriggersTableTextBlock
Namespace Prefix: | UAVS_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration